FGFR2 Amplification
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer (NCT05859477) | Kidney Cancer Research Bureau | 2022-06-05 |
| Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372) | xCures | 2021-11-21 |
| REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors (NCT04526106) | Elevar Therapeutics | 2020-09-02 |
| A Study of TAS-120 in Patients With Metastatic Breast Cancer (NCT04024436) | Taiho Oncology, Inc. | 2020-01-28 |
Track FGFR2 Amplification automatically
Every clearance here is in the API, with alerts when new ones post.